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Abstract
Introduction: Despite recommendations by the Centers for Disease Control (CDC) that all adults be offered
non-targeted HIV screening in all care settings, screening in acute-care settings remains unacceptably low. We
performed an observational study to evaluate an HIV screening pilot in an academic-community partnership health
center urgent care clinic.
Methods: We collected visit data via encounter forms and demographic and laboratory data from electronic
medical records. A post-pilot survey of perceptions of HIV screening was administered to providers and nurses.
Multivariable analysis was used to identify factors associated with completion of testing.
Results: Visit provider and triage nurse were highly associated with both acceptance of screening and completion
of testing, as were younger age, male gender, and race/ethnicity. 23.5% of patients completed tests, although
36.0% requested screening; time constraints as well as risk perceptions by both the provider and patient were cited
as limiting completion of screening. Post-pilot surveys showed mixed support for ongoing HIV screening in this
setting by providers and little support by nurses.
Conclusions: Visit provider and triage nurse were strongly associated with acceptance of testing, which may reflect
variable opinions of HIV screening in this setting by clinical staff. Among patients accepting screening, visit provider
remained strongly associated with completion of testing. Despite longstanding recommendations for non-targeted
HIV screening, further changes to improve the testing and results process, as well as provider education and buy-in,
are needed to improve screening rates.
Keywords: HIV, Screening, Patient care, Urgent care
Introduction
At the end of 2008, approximately 236,400 individuals
were estimated to have undiagnosed HIV in the United
States, representing 20% of the 1.1 million infected indi-
viduals [1]. In order to identify these individuals and ini-
tiate early treatment of HIV, in 2006 the Centers for
Disease Control and Prevention (CDC) recommended
that the United States adopt a voluntary, non-targeted
opt-out HIV screening strategy for all individuals aged
13-64 years presenting to all health care settings where
HIV prevalence is known to be ≥ 0.1% [2]. Attempts at
non-targeted screening, while logical in the primary care
setting, are hindered by many constraints including stigma
and lack of full access to primary care, especially among
the most vulnerable populations [3,4]. In the more an-
onymous and accessible emergency department (ED) set-
ting, adoption of non-targeted screening policies has been
limited by time, concerns about follow up of test results,
and competing priorities. Previous studies have demon-
strated significant increases in detecting undiagnosed HIV
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yet only about 25% of eligible patients complete testing in
these studies [3,7-9]. In settings without explicit opt-out
screening protocols, there were far lower rates of screen-
ing, such as the 1.5% overall screening rate observed
within the 2009 National Hospital Ambulatory Medical
Care Survey (NHAMCS) data [4]. A recent review of
NHAMCS revealed that despite growing recommenda-
tions for non-targeted HIV screening in all clinical set-
tings, no increase in screening in EDs had occurred
between 1993 and 2010. However, HIV testing was sig-
nificantly greater in outpatient ambulatory medical care
departments (OPDs) than in EDs and physician offices,
suggesting that non-targeted screening in urgent care
(UC) settings may continue to be an important setting
in which to expand HIV testing [4].
UCs may be an opportune setting for HIV screening
because physicians may be less constrained by time or
by acuity of the patient’s condition compared to the ED
setting [10]. At the same time, the UC setting maintains
the function of a safety net for patients not linked to pri-
mary care who may have had fewer opportunities to be
screened for HIV. While a logical and previously studied
setting for implementing HIV screening, UCs in prior
studies report lower rates of screening than expected.
These studies cite the burden of pre- and post-test coun-
seling, inconsistent practice patterns, and workflow as
reasons for low screening rates [4,11].
Therefore, we undertook a study of non-targeted HIV
screening at Massachusetts General Hospital-Chelsea
Urgent Care (MGH-CUC), with the goal of creating in-
frastructure to streamline the screening process and in-
crease screening rates. The MGH-CUC is a busy urban
UC within a large academic-community health center,
serving a racially and ethnically diverse underserved pa-
tient population. The health center serves a community
with disproportionate rates of low health literacy, non-
legal immigrant status, and poor social stability. Many
of these patient characteristics not only increase the risk
of acquiring HIV, but also decrease the likelihood that
patients engage in routine primary care. Because no
protocols existed for managing results or new HIV diag-
noses, the baseline rate of HIV screening at this location
was essentially zero. Our goal was to offer HIV screen-
ing to all patients by adding a triage questionnaire and
testing protocol in the UC, as well as education sessions
for all staff. The protocol employed an opt-in testing
strategy since restrictions of Massachusetts legislation
prior to 2012 required written informed consent for
HIV testing (amended to verbal consent on April 27,
2012, which was after completion of this pilot) [12,13].
We examined factors predicting acceptance of HIV
screening and completion of testing in this Urgent Care
setting.
Methods
Study population and clinical pilot
We initiated a four-month pilot to demonstrate feasibility
of non-targeted HIV screening in the UC. We performed
an observational study augmented with electronic medical
record (EMR) review and post-pilot provider and nurse
surveys. We attempted enrollment of all patients age
18-65 presenting to the clinic between October 3, 2011
and January 30, 2012. We excluded minors aged 13-17
from the study, despite screening recommendations,
because of the added complexity of written informed
consent in the State of Massachusetts at the time of the
study [12,14]. At triage, the nurses were requested to
pair a study packet containing the data collection form
(DCF), HIV consent/lab slip, and HIV testing explanatory
material with the clinical encounter form for all patients
aged 18-65 presenting with any complaint. Nursing staff
documented self-report of HIV testing during the last
12 months and patient willingness to participate in HIV
screening during that visit. Providers including physicians
(MDs), nurse practitioners (NPs), and certified physician
assistants (PA-Cs), were requested to offer each patient an
HIV test, regardless of responses in triage, and obtain writ-
ten consent for the test. Following state law, lab slips were
not processed unless patient and provider signatures were
obtained. Interpreters were used as necessary for the
clinical visit. Patients who consented to testing had
whole blood from peripheral venipuncture sent for 4
th
generation EIA/p24Ag HIV test (Abbott ARCHITECT
Combo Assay), with positive tests confirmed with reflex
Western Blot. Patients were then given additional printed
information in multiple languages about HIV with an
explanation of how to obtain their results.
For the first 2.5 months of the study, all patients re-
ceived a provider phone call within 1-3 days of the visit;
negative results were given during the call and patients
with positive results were asked to return to clinic to
receive their results. Interim feedback from providers
suggested that calling all patients with their results was
neither a successful method for reaching patients and
conveying their results nor was it sustainable. For the
remaining 1.5 months of the pilot, patients were in-
structed to obtain their printed results and explanatory
information in envelopes held at the clinic’sr e c e p t i o n
desk. As before, any patients with positive results were
called personally and asked to return for a provider visit
before the written result was released.
Provider and nurse surveys
All providers and nursing staff during the 4 months of
the pilot were recruited to participate in our post-pilot
survey via email. We asked staff to respond to the survey
if they had worked a minimum of 1 shift during the pilot
period. Staff who chose to participate followed a link to
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Likert scales to rate most negative to most positive re-
sponses to several statements regarding HIV testing in
the Urgent Care Center and included free text for add-
itional comments.
Data collection
The DCF accompanied the patient throughout the UC
encounter. Nurses documented question responses dur-
ing triage, and providers documented if patients were
ultimately offered screening and then consented. If pa-
tients either were not offered or did not accept screen-
ing, providers documented the reason screening was
not completed. Study data were collected and managed
u s i n gR E D C a pe l e c t r o n i cd a t ac a p t u r et o o l sh o s t e db y
Partners HealthCare Research Computing, Enterprise
Research Infrastructure & Services (ERIS) group. REDCap
(Research Electronic Data Capture) is a secure, web-based
application designed to support data capture for research
studies [15]. Medical record number (MRN) on the DCF
was linked with the EMR, providing augmented demo-
graphic and clinical data for the patient encounter. HIV
testing history back to 1998 was recorded when available
from the EMR. The EMR was also used to obtain test re-
sults from the pilot and link entries from repeat encoun-
ters. DCFs without MRNs were excluded from analysis, as
were patients who attended nurse-only visits. Patients with
incomplete data due to acuity of visit or provider omission
were included in the study and documented as “not
completed, lack of documentation/other reason” if a
DCF was initiated.
Data analysis
Data tabulated included self-report of HIV testing within
12 months, age category by 5-year increment, gender,
race/ethnicity, Primary Care Physician (PCP) location,
area of residence (same city, within clinic catchment,
outside catchment area), month of UC visit, prior HIV
tests during last 12 months, documentation of HIV test
ever in the EMR, triaging RN, and provider seen. We
evaluated the univariate relationship between each of
these characteristics and completion of screening using
Chi-Square tests. We used logistic regression to identify
independent predictors of completing screening from
the above variables among all participants. We created a
second multivariable model restricted to only those pa-
tients indicating they desired screening in triage. Repeat
visits during the study period were excluded from the
primary analysis but included in a repeater analysis. We
evaluated the rate of repeat visits in which testing took
place both when testing was initially performed and
when testing was not initially performed. We report 95%
confidence intervals and consider a p-value of <0.05 statis-
tically significant throughout. We performed a qualitative
analysis of post-pilot surveys given the small number of
surveys. Data was analyzed with SAS, Version 9.3 (Cary,
NC, USA).
Human subjects
Institutional review board (IRB) approval was obtained
from the Partners Healthcare System Human Subjects
Research Committee for the medical records review and
evaluation of the pilot. The pilot itself was considered
IRB exempt since it was an innovation of national clinical
guidelines. Informed consent was waived for the observa-
tional study as consent was obtained routinely for the HIV
test. A separate IRB application was submitted and re-
ceived approval for the provider/nurse survey. Informed
consent was implied by response to the survey invitation.
The survey recruitment email stated clearly that participa-
tion in the survey was optional and responses were free
from personal or professional repercussions.
Results
HIV screening uptake
Figure 1 illustrates the data collection and HIV screening
process. Over the four-month pilot period, 5,164 vistis
were made by patients aged 18-65 at the Urgent Care
Center out of 8,114 total visits. There were 3,996 unique
eligible patients during the pilot period, 8 of whom had
previously diagnosed HIV (0.2%). We observed 2,465 eli-
gible visits (47.7%) at which DCFs were initiated. The
first visit from each of 2,188 unique patients with eligible
visits was included in the primary analysis (after exclud-
ing 157 repeat visits and 120 visits where the MRN was
missing or the patient was not seen by a provider). The
157 repeat visits made by 141 patients were evaluated in
a separate analysis. Of enrolled unique patients, 514
(23.5%) completed HIV screening at their first visit, ac-
counting for only 12.9% of total eligible patients. 788
(36.0%) patients indicated in triage that they were agree-
able to screening at their initial enrolled visit. Of 141 pa-
tients with 157 repeat visits to the UC during the study
period, 17.3% of those not initially screened completed
screening on a subsequent visit, while only 5.4% tested
more than once during the study period.
One new diagnosis of HIV was made during the screen-
ing pilot, with one additional diagnosis made by targeted
testing of the partner. There were no indeterminate or
false positive tests. Of 514 patients screened, the rate of
previously undiagnosed HIV was 0.19%. The newly diag-
nosed patients were linked to care with an HIV provider
within one week at the same health center.
Patient characteristics
The 2,188 unique patients included in our primary ana-
lysis reflected the demographic makeup of the local popu-
lation [Table 1], with Hispanics predominating (55.7%,
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was 37 years (SD 12.6 years); 61.6% were male. 1439
patients (65.5%) identified a PCP within the hospital’s
primary care network. 49.0% lived within the same city,
40.0% within the adjoining catchment zone of the clinic,
and only 11.1% from outside the local area.
Of patients with a listed in-network PCP, 55.4% had
no HIV test documented in our EMR dating back to 1998.
10.8% had tests documented within the last 12 months.
There was a large disparity with respect to prior testing by
gender, with 53.0% of women and only 30.6% of men hav-
ing documented prior tests; self-report of HIV screening
was more gender-balanced (26.3% of women and 25.1%
of men).
Patient factors associated with completion of screening
Several patient demographic factors were considered in
multivariable analysis predicting completion of HIV
screening. Younger age was strongly associated with
screening acceptance, with screening declining signifi-
cantly with older age (Odds ratio (OR) 5.2, 95% Confi-
dence Interval (CI) 2.2, 12.2 for patients 18-25 compared
against age 60-65, p <0.0001 for trend) [Table 2]. Men
screened more frequently than women (OR 1.4, 95% CI
1.1, 1.8). Race/ethnicity also was a significant factor, with
Hispanic ethnicity (OR 3.7, 95% CI 2.7, 5.2) or black
race (OR 4.1 95% CI 2.5, 6.9) associated with increased
rates of screening compared to non-Hispanic white
patients (p <0.0001). There was no statistically signifi-
cant screening difference between those with a PCP at
the health center, those with an in-system PCP, or no
listed PCP (p=0.24). In the study population, 565
(25.8%) reported that they had previously been tested
for HIV in the past year; this strongly predicted against
screening in this study with an OR 0.3 (95% CI 0.2, 0.3,
p< 0.0001).
In the separate multivariable model restricted to those
788 patients accepting screening, only male gender con-
tinued to be a significant patient factor associated with
completing the screening test (OR 1.6, 95% CI 1.1, 2.2,
p= 0.01).
Association of provider and nurse on completion of
screening
During the four-month pilot period, a staff of 19 clinicians,
including Internal Medicine and Medicine-Pediatrics
physicians (MDs), NPs, and PA-Cs, provided care, and
11 RNs triaged patients at the UC. In multivariable ana-
lysis, the visit provider and the triaging RN were each
independent factors associated with completion of screen-
ing, contributing more highly in both effect size and level
of significance of association (p=0.0005 for RN, <0.0001
for provider) than many individual patient demographic
factors [Table 2 for individual ORs]. There was a 2.6-fold
difference in screening rates between those seeing the RNs
with the lowest and highest odds of screening completion
Figure 1 Patient flow through urgent care clinic during the four month study period. One new diagnoses resulted from screening.
One additional diagnosis resulted from targeted partner testing of the study patient.
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ference in testing rates among providers. In the subset
of patients “accepting screening”, the odds of completing
screening varied more than 90-fold between providers
(p < 0.0001). Point estimates suggest that NPs and PA-Cs
tested at lower rates than MDs.
Acceptance of screening vs completion of HIV test
Starting with all patients age 18-65 eligible for screening,
we witnessed a “screening cascade” with drop-offs mea-
sured at each phase from entry in the clinic to completion
of screening and retrieval of results [Figure 2]. In the flow
through the clinic visit, there were clear points where
screening opportunities were lost. As described above,
52.3% of eligible visits did initiate a screening question-
naire (DCF) at triage. While 36.0% of patients in those ob-
served visits did accept screening at triage, only 23.5%
actually completed the test. 1294 (77.3%) of the 1674 per-
sons not screened had reasons documented that we cate-
gorized as visit-based or potentially modifiable factors,
such that under different circumstances (less acute visit,
different provider) the patient may have accepted and
Table 1 Baseline demographic characteristics of patients presenting to the urgent care during the HIV screening pilot
Total sample Accepting HIV screening Tested for HIV Not tested for HIV
Variable N=2188 N=788 (36.0) N=514 (23.5) N=1674 (76.5)
Age 37.1 +/- 12.6 34.5+/-11.7 33.8 +/- 11.233.8 +/- 11.2 38.1 +/- 12.8
Male 1342 (61.3) 471 (59.8) 291 (56.6) 1051 (62.8)
Male Gender 1342 (61.3) 471 (59.8) 471 (59.8) 1051 (62.8)
Female Gender 846 (38.7) 317 (40.2) 223 (43.4) 623 (37.2)
Race/Ethnicity
Non-Hispanic White 610 (28.0) 112 (14.2) 61 (11.9) 549 (32.8)
Hispanic 1219 (55.7) 556 (70.6) 373 (72.6) 846 (50.5)
African/Black 127 (5.8) 54 (6.9) 40 (7.8) 87 (5.2)
Asian/Pacific Islander 49 (2.2) 11 (1.4) 6 (1.2) 43 (2.6)
Other/Not Listed 183 (8.4) 55 (7.0) 34 (6.6) 149 (8.9)
Area of Residence†
Same Zip Code 1072 (49.0) 444 (56.4) 307 (59.7) 765 (45.7)
Clinic Catchment 874 (40.0) 281 (35.7) 169 (32.9) 705 (42.1)
Outside Catchment 242 (11.1) 63 (8.0) 38 (7.4) 204 (12.2)
Pilot Month of Visit Date
1 789 (36.1) 323 (41.0) 202 (39.3) 587 (35.1)
2 583 (26.7) 184 (23.4) 131 (25.5) 452 (27.0)
3 397 (18.1) 128 (16.2) 77 (15.0) 320 (19.1)
4 419 (19.5) 153 (19.4) 104 (20.2) 315 (18.8)
PCP Location
At Same Location 989 (45.0) 360 (45.7) 234 (45.5) 750 (44.8)
In System‡ 442 (20.5) 134 (17.0) 93 (18.1) 355 (21.1)
No In System PCP 756 (34.6) 294 (37.3) 187 (36.4) 569 (34.0)
Prior HIV Test by EMR
Ever 966 (44.6) 722 (43.1) 248 (48.3)
> 1 year ago 737 (33.4) 541 (32.3) 192 (37.4)
Within 1 year 239 (10.8) 181 (10.8) 56 (10.9)
Prior HIV Test by Self-Report
Within 1 year 565 (25.8) 261 (71.7) 103 (28.3)
Total Patients 2188 788 (36.0) 514 (23.5) 1674 (76.5)
Data are No. (percentage) +/- Standard Deviation.
Abbreviations: HIV, Human Immunodeficiency Virus; PCP, Primary Care Physician; EMR, Electronic Medical Record.
†Local: same city and zip code as clinic, Clinic Catchment Area: The 5 towns/cities encompassing the 6 zip codes from which >85% of UC population is drawn,
Outside Clinic Catchment: a zip code not other than above.
‡In system PCP defined as affiliation with any primary MD or NP affiliated with Partners Healthcare System.
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multivariate analysis
Full sample (n=2188) Persons accepting HIV screening at triage (n=788)
Characteristic OR (95%CI) p-value OR (95%CI) p-value
<0.0001 0.2
18 to 24 5.2 (2.2, 12.2) 5.5 (1.7,17.3)
25 to 29 3.8 (1.6, 9.1) 4.2 (1.3, 13.6)
30 to 34 4.9 (2.0, 11.6) 4.8 (1.5, 15.3)
35 to 39 3.0 (1.2, 7.3) 4.1 (1.2, 13.6)
40 to 44 2.8 (1.2, 6.9) 4.4 (1.3, 14.8)
45 to 49 2.6 (1.1, 6.4) 4.3 (1.2, 14.9)
50 to 54 1.9 (0.8, 4.8) 3.4 (0.9, 12.2)
55 to 59 1.0 (0.7, 5.0) 2.5 (0.7, 9.7)
60 to 65 ref ref
Gender
0.004 0.01
Male 1.4 (1.1, 1.8) 1.6 (1.1, 2.2)
Female ref ref
Month
0.56 0.94
1 ref ref
2 0.8 (0.6, 1.1) 1.1 (0.7, 1.8)
3 0.8 (0.6, 1.2) 0.9 (0.6, 1.6)
4 0.9 (0.7, 1.3) 1.0 (0.6, 1.7)
Area of Residence
0.08 0.08
Outside Clinic Catchment 0.8 (0.6, 1.0) 0.7 (0.5, 1.0)
Within Catchment 0.7 (0.4, 1.0) 0.7 (0.4, 1.4)
Same Zip Code ref ref
Race
<0.0001 0.23
Black/African 4.1 (2.5, 6.9) 2.0 (0.9, 4.4)
Asian/Pacific Islander 1.3 (0.5, 3.2) 0.5 (0.1, 2.1)
Hispanic 3.7 (2.7, 5.2) 1.5 (0.9, 2.4)
Other/Unknown 2.0 (1.2, 3.2) 1.2 (0.6, 1.5)
Non-Hispanic White ref ref
PCP Location
0.24 0.44
No In System PCP 1.3 (1.0, 1.7) 1.0 (0.6, 1.5)
In System PCP 1.1 (0.8, 1.5) 1.3 (0.8, 2.2)
At Same Location ref ref
Self-Report of HIV Test Within 1 Year
<0.0001 0.32
Yes 0.3 (0.2, 0.3) 0.7 (0.4, 1.1)
Not Reported 0.4, (0.1, 1.2) 1.2 (0.2, 7.3)
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multivariate analysis (Continued)
No ref ref
HIV Test in EMR
0.008
Within 1 year 1.6 (1.1, 2.5) 1.1 (0.6, 2.0)
1 year ago 1.5 (1.1, 1.9) 1.3 (0.8, 1.9)
Never ref ref
Triage RN
0.0005 0.19
A 1.0 (0.5, 2.1) 1.0 (0.4, 2.9)
B 1.5 (0.5, 4.2) 5.2 (0.5, 49.8)
C 1.8 (1.0, 3.3) 1.7 (0.7, 4.2)
D 1.2 (0.6, 2.5) 1.3 (0.4, 3.8)
E 1.6 (0.9, 2.8) 2.6 (1.1, 5.1)
F 1.1 (0.8, 1.5) 1.4 (0.9, 2.2)
G 1.3 (0.6, 2.9) 1.6 (0.5, 5.0)
H 2.3 (1.4, 3.9) 2.4 (1.2, 5.1)
I 2.6 (1.7, 4.0) 1.9 (1.0, 3.4)
J 1.2 (0.2, 6.7) 0.4 (0.1, 2.9)
K ref ref
Provider
<0.0001 <0.0001
A 2.9 (1.6, 5.3) 3.4 (1.6, 7.0)
B 3.3 (1.8, 6.0) 4.9 (2.1, 11.3)
C 6.9 (3.3, 14.4) 46.1 (5.5, 390.7)
D 2.4 (1.2, 4.6) 3.0 (1.2, 7.4)
E 2.4 (1.0, 5.8) 4.3 (1.1, 16.8)
F 4.6 (1.9, 11.0) 11.1 (2.1, 60.3)
G 2.7 (1.3, 5.8) 3.8 (1.2, 12.4)
H 2.2 (1.2, 4.0) 2.6 (1.3, 5.5)
I 2.1 (0.6, 7.5) 2.2 (0.4, 11.8)
J 2.2 (0.9, 5.4) 4.9 (1.1, 21.1)
K 1.6 (0.6, 4.5) 2.2 (0.5, 9.3)
L 7.6 (3.4, 17.0) 14.1 (3.4, 58.2)
M 1.0 (0.2, 5.4) 2.5 (0.2, 32.5)
N* 1.7 (0.8, 3.4) 1.7 (0.7, 4.3)
O* 1.6 (0.9, 2.9) 1.5 (0.7, 4.3)
P* 1.0 (0.5, 2.2) 0.5 (0.2, 1.3)
Q* 1.6 (0.8, 3.2) 1.6 (0.7, 4.0)
R* 2.5 (1.2, 5.2) 1.8 (0.7, 4.4)
S* 3.6 (1.3, 10.4) 10.1 (1.1, 91.2)
T ref ref
Abbreviations: PCP, Primary Care Physician; HIV, Human Immunodeficiency Virus; EMR, Electronic Medical Record.
*Denotes mid-level providers, either certified physicians assistants (PA-C) or nurse practitioners (NP).
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reasons for not completing tested included visit acuity/
lack of time (8.1%) or provider not offering testing
(8.4%) [See Table 3 for full data]. A small proportion of
patients desired HIV screening but provider deferred
testing to an upcoming PCP visit (1.2%) or prenatal
appointment (1.1%). We included in the “potentially
modifiable” list the 552 visits (33%) for which no reason
was documented. The majority of these visits had a
time-sensitive chief complaint such as chest pain or for-
eign body in the eye listed in the medical record. An
additional 28.1% of visits where screening was not com-
pleted were associated with a “patient-based factor”,w h i c h
we define as a feature of that patient unlikely to change
if other visit-based variables were different. Such patient-
based reasons included patient report of recent testing
in last year (19.8%) or greater than 1 year ago without
recent perceived risk (3.5%) or fear of needles (0.24%)
[Table 3]. For several encounters, greater than 1 reason
was recorded.
Provider and nurse post-pilot surveys
Seven of 11 eligible RNs (63.6%) completed a post-pilot
survey. Only one RN felt it was acceptable to continue
HIV screening after the pilot, 3 had a neutral/no opinion,
and 3 were slightly opposed to continue screening. There
were less strong patterns with response to other ques-
tions and willingness to formalize the screening process;
the majority of responses were neutral to slightly nega-
tive across the board, especially with respect to logistical
difficulties caused by adding screening to the visit and
negative impact of work-flow [Figure 3a]. Several open-
ended responses from RNs included concerns that it was
not appropriate to involve RNs in HIV screening or that
RNs did not feel well equipped to discuss patients’ risk of
HIV or answer patient questions on this topic.
Twelve of 19 eligible providers (63.1%) completed post-
pilot surveys with questions that differed slightly from
those in the RN survey as appropriate for roll in HIV
screening. Of these, 58.3% were in favor of continuing
uniform non-targeted screening after completion of the
pilot. 25% preferred to screen only a subset of patients,
for example, targeted screening based on patient factors
and when sufficient visit time allowed. One provider each
wished to screen only if the patient requested screening or
not at all. Overall, there was a trend in willingness to con-
tinue HIV screening following the pilot with positive re-
sponses to the following: provider comfort with discussing
screening, perceptions of responsibility of UC providers to
participate in screening, appropriateness of time use, bur-
den of results management, and value added to patients
by offering screening as a service [Figure 3b].
Figure 2 Cascade of Lost Testing Opportunities. This cascade shows lost opportunities for screening at each phase in the visit. The largest
decrements were in identifying appropriate patients to screen at triage (54.8% of eligible patients identified and enrolled) and obtaining patient
acceptance of screening (36.0% of those identified to screen). Of the 788 patients amenable to screening, 34.8% did not complete the consent
and blood work. *Approximately 10% returned to receive negative test results. 0.19% of screened patients were found to have HIV.
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We evaluated predictors of completing non-targeted
HIV screening in an Urgent Care center at an academic-
community partnership health center serving a racially
and ethnically diverse and socioeconomically disadvan-
taged community. We attempted to enhance the nil HIV
screening rate at baseline by establishing a protocol at
the UC to offer routine screening. The overall rate of
testing at the end of the study was 23.5%, within the
range reported by prior studies performed in ED and UC
settings [3,7-9]. In the process, we identified a previously
unrecognized, independent predictor for completing HIV
screening: the health care professional who treated the
patient in the UC. Of the responders to the survey,
about half of providers were neutral or opposed to the
UC setting being the appropriate setting for a screening
test, but as illustrated by the heat map of survey responses
[Figure 3b], a majority of respondents favored continuing
screening. Altogether, provider opinion, whether in favor
or opposition to screening, likely contributes to broad
range of screening completion rates by provider. This
suggests that successful implementation of non-targeted
screening is unlikely to occur until there is buy-in by
providers in UCs and EDs, despite strong national-level
guidelines.
Providers may have offered, completed or deferred
screening based on perceived time constraints or be-
cause they felt screening was of low value to the patient
encounter because of lack of perceived risk, among other
factors. While the latter runs counter to the principle of
implementing non-targeted testing in acute-care settings,
the finding is consistent with previous studies [17,18].
Other studies have demonstrated that physicians have
variable knowledge about the CDC recommendations,
and when they are informed, often have doubts about
guidelines, fear of mistrust from their patients, or fear
of what to do with a positive result [17-19].
RN responders to the survey were largely neutral
about their role as it related to the screening pilot and
were relatively negative with respect to whether they
would support non-targeted HIV screening moving for-
ward. In this model of HIV screening, the particular
nurse screening a patient could strongly influence the
patient’s response as to whether or not he/she was amen-
able to screening. Since willingness to be screened was
evaluated by the triage RN, the group accepting screening
was likely selected based on a combination of RN opinion
on screening in general, and how the RN did or did not re-
solve their own perceptions and patient perceptions about
who is at risk for HIV.
Based on our results and a recently published study
reporting that RN-initiated screening has lower uptake
than provider-initiated screening [7], we do not recom-
mend that future non-targeted screening programs use
RN-initiated screening protocols in the ED or UC setting.
However, because HIV screening inherently involves RNs
for other steps in the screening process, it is important to
include nursing staff in education and design of HIV
screening programs.
In this pilot we identified several points during the en-
counter where improvements could be made to increase
both screening uptake and test completion. As depicted in
Figure 2, in the flow through the clinic visit, there were
clear points where testing opportunities were lost; while
there may be several patient factors impacting uptake of
screening, our pilot suggests that the person offering the
screening is extremely influential in the patient’st e s t i n g
decision. Not all patients were enrolled in the pilot
and offered HIV screening in triage. A lower number
of patients than expected were agreeable to screening,
possibly reflecting initiation of screening by triage RNs.
Table 3 Reported reasons HIV screening not performed
during urgent care visit
Reason screening not performed Number (%)
Sums to > 100% with multiple responses
Visit-Based or Potentially Modifiable Factors 1294 (77.3)
Provider felt patient to not be at risk 60 (3.6)
Patient felt themselves to be at low risk 367 (21.9)
Provider did not offer 141 (8.4)
Visit Acuity or Lack of Time
† 135 (8.1)
Patient desired testing, deferred to future PCP visit 20 (1.2)
Pregnancy diagnosed: testing deferred to PNV 8 (1.1)
Patient or provider perceived cost of testing
‡ 7 (0.42)
Patient felt too ill to test 4 (0.24)
Other reason not listed/lack of documentation
† 552 (33.0)
Patient-Based Factors 471 (28.1)
Patient reported testing in the last 12 months 332 (19.8)
Patient declined, no reason given 68 (4.1)
Patient reported testing > 12 mos prior 59 (3.5)
Previously known HIV+ status 8 (0.48)
Fear of needles 4 (0.24)
Total Patients Not Screened/Enrolled Patients 1674 (100%)
Abbreviations: PNV, Pre-Natal Visit.
†135 visits documented high-acuity of visit on the study form as reason testing
not performed, however EMR review showed that the vast majority of the 552
visits with “Other Reason Not Listed” were also visits of high acuity, but without
provider documentation on the study form. Examples of “High-acuity visits”
determined by EMR review included presentation with probable cardiac
chest pain, asthma exacerbation, foreign body in the eye, or other visit requiring
emergent medical interventions and/or ambulance transfer to Emergency
Department. Most visits fitting the above description of “High-acuity” also
had incomplete HIV screening documentation, presumably because of the
urgency of the patient encounter.
‡The Commonwealth of Massachusetts offers “universal” health care coverage.
For those not already enrolled in the hospital-based safety net system, the vast
majority of patients are enrolled following first contact with CHC and covered
retroactively, including all lab testing associated with the visit. Despite education
regarding this, a small number of providers and/or patients remained concerned
about cost of testing.
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findings that younger age groups, Hispanics, and Blacks
were more likely to complete HIV screening [11,16].
Limitations
Our study has limitations. We performed a single center
study, with the intent to evaluate predictors for screen-
ing at our site only; patients may have had previous tests
performed with outside providers and we relied on their
self-report of these tests. Furthermore, a large propor-
tion of visits meeting criteria for enrollment in the study
were not enrolled at triage. As the pilot was performed
in Massachusetts prior to April 2012, the legal obligation
to use written informed consent forced an opt-in strategy.
This created an additional barrier to screening that is no
longer required by most states. Settings where point-of-
care testing is used and where written consent is no longer
required may have greater screening uptake.
Conclusions
The wide variability in completion of screening associ-
ated with interacting with different care providers has
not previously been reported in the literature. In this
single-center observational study we found that the pro-
vider and the nurse serving each study participant were
each independently associated with acceptance of test-
ing. Based upon our qualitative data, time and comfort
level with HIV testing may have contributed to low
rates of testing.
While the pilot aimed to educate providers and stream-
line the screening process, screening drop-off still oc-
curred at points of contact between patients and clinical
staff. Survey data suggested that providers maintain bias
against uniform non-targeted screening. We can use
this knowledge as an opportunity to educate providers
on the CDC guidelines and its rationale in order to in-
crease screening in acute care settings. This issue war-
rants future operational research and clinical innovation
Figure 3 Heat map representation of post-pilot survey responses a) nursing survey responses. 7 of 11 eligible RNs responded via secure
online anonymous survey. Response scale converted to color coding from “Most Positive” to “Most Negative” response based responses to
questions given in the form of Likert Scales as per key. b) Provider survey responses. 12 of 19 eligible providers responded via secure online
anonymous survey. Response scale converted to color coding from “Most Positive” to “Most Negative” response based responses to questions
given in the form of Likert Scales as per key. The final column demonstrates provider self-prediction of their future testing practices after completion of
the screening pilot (Screen all patients, only screen some patients depending on patient request/other factors, not perform HIV screening).
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